These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 32945455)
1. Ginsenoside Rg1 reduces β‑amyloid levels by inhibiting CDΚ5‑induced PPARγ phosphorylation in a neuron model of Alzheimer's disease. Quan Q; Li X; Feng J; Hou J; Li M; Zhang B Mol Med Rep; 2020 Oct; 22(4):3277-3288. PubMed ID: 32945455 [TBL] [Abstract][Full Text] [Related]
2. CDK5 Participates in Amyloid-β Production by Regulating PPARγ Phosphorylation in Primary Rat Hippocampal Neurons. Quan Q; Qian Y; Li X; Li M J Alzheimers Dis; 2019; 71(2):443-460. PubMed ID: 31403945 [TBL] [Abstract][Full Text] [Related]
3. Ginsenoside Rg1 attenuates β-amyloid generation via suppressing PPARγ-regulated BACE1 activity in N2a-APP695 cells. Chen LM; Lin ZY; Zhu YG; Lin N; Zhang J; Pan XD; Chen XC Eur J Pharmacol; 2012 Jan; 675(1-3):15-21. PubMed ID: 22166376 [TBL] [Abstract][Full Text] [Related]
4. Ginsenoside Rg1 decreases Aβ(1-42) level by upregulating PPARγ and IDE expression in the hippocampus of a rat model of Alzheimer's disease. Quan Q; Wang J; Li X; Wang Y PLoS One; 2013; 8(3):e59155. PubMed ID: 23520555 [TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Rg1 promotes β‑amyloid peptide degradation through inhibition of the ERK/PPARγ phosphorylation pathway in an Alzheimer's disease neuronal model. Quan Q; Ma X; Li M; Li X; Yuan H Exp Ther Med; 2024 Jan; 27(1):31. PubMed ID: 38125359 [TBL] [Abstract][Full Text] [Related]
6. Effects of ginsenoside Rg1 on the expression of toll-like receptor 3, 4 and their signalling transduction factors in the NG108-15 murine neuroglial cell line. Zhao BS; Liu Y; Gao XY; Zhai HQ; Guo JY; Wang XY Molecules; 2014 Oct; 19(10):16925-36. PubMed ID: 25340298 [TBL] [Abstract][Full Text] [Related]
7. Ginsenoside Re reduces Aβ production by activating PPARγ to inhibit BACE1 in N2a/APP695 cells. Cao G; Su P; Zhang S; Guo L; Zhang H; Liang Y; Qin C; Zhang W Eur J Pharmacol; 2016 Dec; 793():101-108. PubMed ID: 27840193 [TBL] [Abstract][Full Text] [Related]
8. Pioglitazone Reduces β Amyloid Levels Quan Q; Qian Y; Li X; Li M Front Aging Neurosci; 2019; 11():178. PubMed ID: 31379559 [TBL] [Abstract][Full Text] [Related]
9. Multi-faced neuroprotective effects of Ginsenoside Rg1 in an Alzheimer mouse model. Fang F; Chen X; Huang T; Lue LF; Luddy JS; Yan SS Biochim Biophys Acta; 2012 Feb; 1822(2):286-92. PubMed ID: 22015470 [TBL] [Abstract][Full Text] [Related]
10. Notoginseng Saponin Rg1 Prevents Cognitive Impairment through Modulating APP Processing in Aβ Liu SZ; Cheng W; Shao JW; Gu YF; Zhu YY; Dong QJ; Bai SY; Wang P; Lin L Curr Med Sci; 2019 Apr; 39(2):196-203. PubMed ID: 31016510 [TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rg1 ameliorates hippocampal long-term potentiation and memory in an Alzheimer's disease model. Li F; Wu X; Li J; Niu Q Mol Med Rep; 2016 Jun; 13(6):4904-10. PubMed ID: 27082952 [TBL] [Abstract][Full Text] [Related]
12. Ginsenoside Rg1 promotes nonamyloidgenic cleavage of APP via estrogen receptor signaling to MAPK/ERK and PI3K/Akt. Shi C; Zheng DD; Fang L; Wu F; Kwong WH; Xu J Biochim Biophys Acta; 2012 Apr; 1820(4):453-60. PubMed ID: 22178929 [TBL] [Abstract][Full Text] [Related]
13. Exploring the potential mechanism of ginsenoside Rg1 to regulate ferroptosis in Alzheimer's disease based on network pharmacology. Deng X; Qiu Z; Chen X; Liu J; Wang X; Li J; Zhang J; Cui X; Fu Y; Jiang M Eur J Pharmacol; 2024 Sep; 979():176859. PubMed ID: 39067563 [TBL] [Abstract][Full Text] [Related]
14. Cdk5 protein inhibition and Aβ42 increase BACE1 protein level in primary neurons by a post-transcriptional mechanism: implications of CDK5 as a therapeutic target for Alzheimer disease. Sadleir KR; Vassar R J Biol Chem; 2012 Mar; 287(10):7224-35. PubMed ID: 22223639 [TBL] [Abstract][Full Text] [Related]
15. Effects of ginsenoside Rg1 or 17β-estradiol on a cognitively impaired, ovariectomized rat model of Alzheimer's disease. Zhang X; Wang J; Xing Y; Gong L; Li H; Wu Z; Li Y; Wang J; Wang Y; Dong L; Li S Neuroscience; 2012 Sep; 220():191-200. PubMed ID: 22728092 [TBL] [Abstract][Full Text] [Related]
16. Ginsenoside Rg1 suppressed inflammation and neuron apoptosis by activating PPARγ/HO-1 in hippocampus in rat model of cerebral ischemia-reperfusion injury. Yang Y; Li X; Zhang L; Liu L; Jing G; Cai H Int J Clin Exp Pathol; 2015; 8(3):2484-94. PubMed ID: 26045754 [TBL] [Abstract][Full Text] [Related]
17. GEPT extract reduces Abeta deposition by regulating the balance between production and degradation of Abeta in APPV717I transgenic mice. Tian J; Shi J; Zhang L; Yin J; Hu Q; Xu Y; Sheng S; Wang P; Ren Y; Wang R; Wang Y Curr Alzheimer Res; 2009 Apr; 6(2):118-31. PubMed ID: 19355846 [TBL] [Abstract][Full Text] [Related]
18. Rg1 exhibits neuroprotective effects by inhibiting the endoplasmic reticulum stress-mediated c-Jun N-terminal protein kinase apoptotic pathway in a rat model of Alzheimer's disease. Mu JS; Lin H; Ye JX; Lin M; Cui XP Mol Med Rep; 2015 Sep; 12(3):3862-3868. PubMed ID: 26016457 [TBL] [Abstract][Full Text] [Related]
19. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease. Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867 [TBL] [Abstract][Full Text] [Related]
20. Ginsenoside Rg1 protects primary cultured rat hippocampal neurons from cell apoptosis induced by β-amyloid protein. Gong L; Li SL; Li H; Zhang L Pharm Biol; 2011 May; 49(5):501-7. PubMed ID: 21438847 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]